CHAPEL HILL, N.C.--(BUSINESS WIRE)--Sept. 13, 2006--POZEN Inc.
(NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the
company's chairman, president and chief executive officer, will
present at the UBS 2006 Global Life Sciences Conference on Monday,
September 25, 2006 at 10:30 a.m. at the Grand Hyatt in New York City.
Dr. Plachetka's presentation will be webcast and archived on POZEN's
home page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. POZEN's
efforts are focused primarily on the development of pharmaceutical
products for the treatment of acute and chronic pain and other
pain-related conditions. POZEN has development and commercialization
alliances with GlaxoSmithKline and AstraZeneca. The company's common
stock is traded on The Nasdaq Stock Market under the symbol "POZN".
For detailed company information, including copies of this and other
press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Chief Financial Officer
Director, Investor Relations